SunRock Biopharma
↗Santiago de Compostela, Spain
SunRock Biopharma is a biotechnology company based in Spain, focused on the development of innovative antibody-based therapies for the treatment of cancer. The company leverages proprietary technology platforms to discover and develop novel therapeutic candidates targeting unmet medical needs in oncology.
As a research-driven organization, SunRock Biopharma emphasizes the development of monoclonal antibodies and potentially other antibody-derived modalities to address aggressive or difficult-to-treat solid tumors. The company operates primarily in the preclinical and early-stage development space.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Private
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:mAb
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Emerging
LINKS
Website:sunrockbiopharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SunRock Biopharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SunRock Biopharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.